METROPOLITAN LIFE INSURANCE CO/NY - GALENA BIOPHARMA INC ownership

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of GALENA BIOPHARMA INC
ValueSharesWeighting
Q2 2016$71,000
-60.3%
152,527
+25.2%
0.00%0.0%
Q4 2015$179,000
+10.5%
121,805
+18.9%
0.00%0.0%
Q3 2015$162,000
+84.1%
102,436
+97.2%
0.00%0.0%
Q2 2015$88,000
-38.5%
51,933
-49.6%
0.00%0.0%
Q1 2015$143,000
-29.6%
103,034
+4.7%
0.00%0.0%
Q3 2014$203,000
-22.8%
98,452
+14.7%
0.00%
-50.0%
Q2 2014$263,000
+38.4%
85,809
+12.7%
0.00%
+100.0%
Q1 2014$190,000
-49.7%
76,1230.0%0.00%
-66.7%
Q4 2013$378,000
+118.5%
76,1230.0%0.00%
+200.0%
Q3 2013$173,000
+5.5%
76,123
+3.3%
0.00%0.0%
Q2 2013$164,00073,7140.00%
Other shareholders
GALENA BIOPHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Hoxton Financial, Inc. 50,000$74,0000.04%
Alyeska Investment Group, L.P. 1,593,277$2,342,0000.02%
DUMONT & BLAKE INVESTMENT ADVISORS LLC 31,000$46,0000.02%
GROUP ONE TRADING, L.P. 1,346,904$1,980,0000.02%
Matisse Capital 17,000$25,0000.01%
COMPTON CAPITAL MANAGEMENT INC /RI 15,000$22,0000.01%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 12,150$18,0000.01%
EQUITEC SPECIALISTS, LLC 19,700$29,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 153,375$225,0000.00%
OPPENHEIMER & CO INC 94,300$138,0000.00%
View complete list of GALENA BIOPHARMA INC shareholders